Biotechnology Market Research Reports & Industry Analysis

Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.

Biotech Market Research to Fuel Business Growth

Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:

  • Current market performance, industry outlooks, and industry lifecycles
  • Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
  • Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
  • Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies

Stay Ahead with our Biotechnology Industry Analysis

The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.

...Show More ...Show Less


Biotechnology Industry Research & Market Reports

  • Worldwide Biotech September 2024

    ... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry. Read More

  • Biotech Business September 2024

    ... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More

  • Analytical Instruments: United States

    ... instruments; process control instruments; electrical measuring instruments; and other analytical instruments such as a materials testing, meteorological observation, and surveying. To illustrate historical trends, total demand, total shipments, the various segments, and trade are provided ... Read More

  • Global Permeable Cell Culture Insert Market Research Report 2024

    ... a CAGR of 6.36% during the forecast period 2024-2030. North American market for Permeable Cell Culture Insert is estimated to increase from $ 50.9 million in 2023 to reach $ 76.95 million by 2030, at ... Read More

  • Enzyme-linked Immunosorbent Assay (Elisa) Testing

    ... is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Sandwich ELISA Testing, one of the segments analyzed in the report, is expected to record a ... Read More

  • Carbohydrase

    ... of 5.6% over the analysis period 2023-2030. Food & Beverage Application, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.2 Billion by the end of the ... Read More

  • Cell Culture Protein Surface Coating

    ... is expected to reach US$4.0 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2023-2030. Self-coating, one of the segments analyzed in the report, is expected to record a 14.0% CAGR ... Read More

  • Cell Separation Technologies

    ... by 2030, growing at a CAGR of 15.1% over the analysis period 2023-2030. Research Laboratories & Institutes End-Use, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach ... Read More

  • Bone Marrow Transplant

    ... by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Myeloma Indication, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$4.8 Billion by ... Read More

  • Bread Improvers

    ... at a CAGR of 4.5% over the analysis period 2023-2030. Emulsifiers, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.0 Billion by the end of the ... Read More

  • CAR T-cell Therapy

    ... by 2030, growing at a CAGR of 21.9% over the analysis period 2023-2030. DLBCL Indication, one of the segments analyzed in the report, is expected to record a 18.6% CAGR and reach US$5.1 Billion by ... Read More

  • Silage Additives

    ... at a CAGR of 4.8% over the analysis period 2023-2030. Legumes Application, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.7 Billion by the end of ... Read More

  • Bioprocess Containers

    ... at a CAGR of 23.6% over the analysis period 2023-2030. Upstream Processes Application, one of the segments analyzed in the report, is expected to record a 26.4% CAGR and reach US$19.6 Billion by the end ... Read More

  • Brewing Enzymes

    ... at a CAGR of 5.7% over the analysis period 2023-2030. Beer Application, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$434.2 Million by the end of ... Read More

  • Live Cell Imaging

    ... by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Cell Biology Application, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$1.8 Billion ... Read More

  • Cell Therapy

    ... at a CAGR of 14.1% over the analysis period 2023-2030. Research Application, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$31.2 Billion by the end of ... Read More

  • Cell Viability Assays

    ... by 2030, growing at a CAGR of 7.1% over the analysis period 2023-2030. Consumables Component, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$5.3 Billion by ... Read More

  • Expression Vectors

    ... at a CAGR of 5.5% over the analysis period 2023-2030. Therapeutic Application, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$389.9 Million by the end of ... Read More

  • Gel Permeation Chromatography Systems

    ... reach US$2.7 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Pharma & Biotech Companies End-Use, one of the segments analyzed in the report, is expected to record a 5.8% ... Read More

  • Medical Composites

    ... at a CAGR of 8.4% over the analysis period 2023-2030. Dental Application, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$936.0 Million by the end of ... Read More

  • Single-Use Bioreactors

    ... at a CAGR of 15.1% over the analysis period 2023-2030. Single-Use Bioreactor Systems, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$6.1 Billion by the end ... Read More

  • Food Ultrasound

    ... at a CAGR of 4.6% over the analysis period 2023-2030. High-intensity, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$96.5 Million by the end of the ... Read More

  • Mass Spectrometry

    ... at a CAGR of 3.8% over the analysis period 2023-2030. Hybrid Platform, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$3.7 Billion by the end of ... Read More

  • Microbiome Therapeutics

    ... at a CAGR of 56.9% over the analysis period 2023-2030. C. Difficile Infection, one of the segments analyzed in the report, is expected to record a 53.2% CAGR and reach US$7.3 Billion by the end ... Read More

  • Monoclonal Antibody Therapy Market

    ... 263.28 billion in 2024 to USD 792.37 billion by 2032, exhibiting a CAGR of 14.8% during the forecast period of 2024-2032. The COVID-19 pandemic boosted several R&D activities in monoclonal antibodies (mAbs) and they experienced ... Read More

Cookie Settings